Happy Health lands $75M series A to move care into the home, starting with sleep
What's the deal? Happy Health has raised a $75 million series A to build its AI-powered platform for continuous home-based care. ARCH Venture Partners and OpenLoop led the round for the Austin, Texas-based digital health company.
What's the endgame? The startup wants physicians to detect disease earlier, outside the hospital. Founder and chief executive officer Dustin Freckleton said Happy Health is building a healthcare system that acts before people become sick.
Why now? Sleep is Happy Health's first application because it offers a rich window into human physiology. Its clinical-grade Happy Ring won US Food and Drug Administration (FDA) approval in October 2024, followed by clearance for at-home sleep testing in June 2025.
How does the product work? The Happy Sleep platform pairs the ring with a clinical care team of board-certified sleep physicians and is in network with most major insurers, including Blue Cross and Medicare. The device collects more than 2,800,000 biometric measurements each night and can diagnose obstructive sleep apnea, insomnia, and other conditions in as few as three nights with 98% accuracy, according to the company.
Rather than comparing patients against population averages, the platform builds an individual physiological baseline for each person. Happy Health says the same approach could eventually extend to cardiovascular, metabolic, and other chronic diseases.
The signal: At $75 million, the round ranks among the largest US series A deals in internet-of-things over the past four years. That scale reflects growing investor conviction that continuous monitoring can shift diagnosis from the hospital to the home.
Read more: Fierce Healthcare
Image credit: Happy Health
